Breaking News Instant updates and real-time market news.

UNFI

United Natural Foods

$42.77

0.13 (0.30%)

, KR

Kroger

$27.94

-0.02 (-0.07%)

06:35
07/13/18
07/13
06:35
07/13/18
06:35

United Natural Foods positioned for rise of online grocery, says Loop Capital

Loop Capital analyst Andrew Wolf kept his Buy rating and $61 price target on United Natural Foods, saying the company is best positioned to capitalize on the growing shopping trend of buying groceries online. The analyst notes that the company already supplies Whole Foods (AMZN) and Kroger (KR) with natural and specialty foods as well as health and beauty care goods. Wolf adds that United Natural Foods also offers "backstage capabilities and merchandising curation" that serve the broader market as well as independent natural retailers. The analyst further points to the company's 23% sales increase in e-commerce reported in its most recent quarter.

UNFI

United Natural Foods

$42.77

0.13 (0.30%)

KR

Kroger

$27.94

-0.02 (-0.07%)

AMZN

Amazon.com

$1,797.01

43.96 (2.51%)

  • 18

    Jul

  • 26

    Jul

  • 16

    Aug

UNFI United Natural Foods
$42.77

0.13 (0.30%)

06/07/18
LOOP
06/07/18
NO CHANGE
Target $61
LOOP
Buy
United Natural Foods Q3 earnings beat 'more real than not,' says Loop Capital
Loop Capital analyst Andrew Wolf says that while a casual analysis would suggest United Natural Foods' Q3 earnings beat was driven by an unusually large quasi-one time item, his detailed accounting analysis concludes otherwise. He notes the quarter also absorbed $20M of incremental expenses that all but offset the $20.9M gain into income. As such, the analyst views the quality of earnings as "decent" during the quarter. He boosted his fiscal 2018 and 2019 earnings forecasts and keeps a Buy rating on United Natural Foods with a $61 price target.
06/07/18
SPHN
06/07/18
NO CHANGE
Target $43
SPHN
Equal Weight
United Natural Foods price target lowered to $43 from $51 at Stephens
Stephens analyst Ben Bienvenu said United Natural Foods continued to see "very strong" revenue growth across all of its customer channels in Q3, but margins remain under pressure and free cash flow contracted meaningfully as working capital demands intensify. He thinks these trends may persist as the company ramps expenditures and devotes added capacity to service fast growing customers, Bienvenu tells investors. He keeps an Equal Weight rating on United Natural Foods and lowered his price target on the stock to $43 from $51.
06/07/18
WELS
06/07/18
NO CHANGE
Target $45
WELS
Market Perform
United Natural Foods price target lowered to $45 from $50 at Wells Fargo
Wells Fargo analyst Edward Kelly lowered his price target for United Natural Foods to $45 from $50 after the company's Q3 update generally disappointed, as strong sales were more than offset by weak underlying margins and poor transparency around a material accounting change. The analyst reiterates a Market Perform rating on the shares.
06/08/18
BMOC
06/08/18
NO CHANGE
Target $41
BMOC
Market Perform
United Natural Foods price target cut to $41 from $50 at BMO Capital
BMO Capital analyst Kelly Bania lowered her price target for United Natural Foods to $41, telling investors in a research note that despite the headline Q3 EPS beat, she believes underlying quality of the quarter was "concerning," as the benefit of stronger sales from lower-margin Whole Foods appears to be pressuring margins and may be coming at the cost of weaker sales with United Natural's smaller/higher-margin customers. This, along with a significant cut to its free cash flow outlook, leaves her Market Perform rated.
KR Kroger
$27.94

-0.02 (-0.07%)

07/06/18
SBSH
07/06/18
INITIATION
SBSH
Buy
Kroger assumed with a Buy at Citi
Citi analyst Gregory Badishkanian assumed coverage of Kroger with a Buy rating. The analyst expects continued comp momentum driven by the completion of additional store optimization projects and the return to inflation.
07/02/18
DBAB
07/02/18
INITIATION
Target $30
DBAB
Hold
Kroger resumed with a Hold at Deutsche Bank
Deutsche Bank analyst Paul Trussell resumed coverage of Kroger with a Hold rating and $30 price target. Management is taking important strategic steps to extend market share gains and position the company for long-term success, but the valuation at current levels "appropriately balances the bull and bear cases," Trussell tells investors in a research note. He wants to sees more improvement in fundamentals or a better entry point before getting more constructive on the shares.
06/29/18
FBCO
06/29/18
NO CHANGE
Target $31
FBCO
Outperform
Kroger's pharmacy customers 'should be fairly sticky,' says Credit Suisse
After Amazon (AMZN) announced plans to buy PillPack, Credit Suisse analyst Judah Frommer said the transaction likely contributed to Kroger's (KR) underperformance on Thursday. While Frommer says Amazon's entry into the retail pharmacy space may shift incremental share toward a nascent channel, the impact to Kroger's profitability in the event it "donates" share "should be somewhat limited." In a research note to investors, Frommer contends that pharmacy customers, some of the supermarket's most loyal, "should be fairly sticky." Frommer has an Outperform rating and $31 price target on Kroger shares.
06/26/18
SBSH
06/26/18
NO CHANGE
Target $34
SBSH
Buy
Kroger price target raised to $34 from $30 at Citi
Citi analyst Alvin Concepcion raised his calendar 2018 EPS estimate for Kroger by 5c and lowered his 2019 and 202 estimates slightly following the company's Q1 report. He also raised his price target on the stock to $34 to due in part to multiple expansion for the peer group. Concepcion maintains a Buy rating on Kroger shares.
AMZN Amazon.com
$1,797.01

43.96 (2.51%)

07/10/18
EVER
07/10/18
UPGRADE
Target $121
EVER
Outperform
Quest Diagnostics upgraded to Outperform at Evercore ISI on improved volume view
As reported earlier, Evercore ISI analyst Ross Muken upgraded Quest Diagnostics (DGX) to Outperform from In Line and raised his price target to $121 from $108. The analyst notes that the company will likely be the beneficiary of improved volumes, stable pricing, heightened M&A and fund flows amid the heightened volatility within the Rx supply chain. Muken believes that the company is "less exposed to political risk and big bad Amazon (AMZN)" competition, while its new management has also effectively reduced costs and deployed capital.
07/11/18
MSCO
07/11/18
NO CHANGE
Target $1700
MSCO
Overweight
Morgan Stanley says Amazon ads, cloud to drive up estimates, cushion investing
Morgan Stanley analyst Brian Nowak believes Amazon's high-margin revenue streams of advertising, AWS and subscription revenue can generate about $25B of EBIT in 2018, which he sees powering upward revisions to estimates while allowing the company to invest at "record levels." Nowak, who notes that his Q2 and Q3 GAAP EBIT estimates are 14% and 47%, respectively, above Street consensus, also notes that contribution from these high-margin revenue streams should only grow over time. Nowak, who keeps an Overweight rating and $1,700 price target on Amazon shares, sees a path in a bull case for the stock to advance to $2,600 per share.
07/12/18
ADAM
07/12/18
NO CHANGE
Target $2000
ADAM
Buy
Amazon.com price target raised to $2,000 from $1,800 at Canaccord
Canaccord analyst Michael Graham raised its price target on Amazon to $2,000 from $1,800 and maintained a Buy rating, noting strong growth prospects. In a research note to investors, Graham says he is the most constructive among the "FANG" stocks on Amazon and Facebook (FB), although he adds that the FANG stocks are trading at a multiple that's low by historical standards but high compared to the past eight years. Graham thinks his revenue estimate of 38% for Q2 could prove to be conservative, and continues to see Amazon having the most robust and durable growth outlook in the group.
07/12/18
ADAM
07/12/18
NO CHANGE
Target $240
ADAM
Buy
Privacy concerns at Facebook linger, but Canaccord says 'constructive' on shares
Canaccord analyst Michael Graham maintained a Buy rating on Facebook (FB) shares ahead of the company's quarterly earnings, telling investors in a research note that he is the most constructive among the "FANG" stocks on Facebook and Amazon (AMZN), although he adds that the FANG stocks are trading at a multiple that's low by historical standards but high compared to the past eight years. Looking ahead, Graham says slowing ad load growth places greater burden for revenue growth on ad pricing, and data and privacy concerns will linger and may intensify, but he still sees a very constructive case for fundamentals and estimates for the rest of the year and find the valuation reasonable relative to growth. The analyst says he is "comfortable" with his $240 price target, which is based on 26x 2019 EPS.

TODAY'S FREE FLY STORIES

CORT

Corcept Therapeutics

$12.46

-0.41 (-3.19%)

, TEVA

Teva

$21.25

0.06 (0.28%)

15:51
10/18/18
10/18
15:51
10/18/18
15:51
Hot Stocks
Corcept slides after Teva gets tentative approval for generic version of Korlym »

An ANDA submitted by Teva…

CORT

Corcept Therapeutics

$12.46

-0.41 (-3.19%)

TEVA

Teva

$21.25

0.06 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

GBT

Global Blood Therapeutics

$38.20

2.42 (6.76%)

15:48
10/18/18
10/18
15:48
10/18/18
15:48
Recommendations
Global Blood Therapeutics analyst commentary  »

Piper Jaffray says FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

ADP

ADP

$142.68

-1.02 (-0.71%)

15:45
10/18/18
10/18
15:45
10/18/18
15:45
Options
ADP call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

XOMA

Xoma

$14.38

-1.65 (-10.29%)

, NVS

Novartis

$86.17

0.83 (0.97%)

15:40
10/18/18
10/18
15:40
10/18/18
15:40
Hot Stocks
Breaking Hot Stocks news story on Xoma, Novartis »

Xoma drops 15% after…

XOMA

Xoma

$14.38

-1.65 (-10.29%)

NVS

Novartis

$86.17

0.83 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

XOMA

Xoma

$14.38

-1.65 (-10.29%)

15:39
10/18/18
10/18
15:39
10/18/18
15:39
Hot Stocks
Xoma says Novartis disclosed CRL received from FDA for canakinumab »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWBK

Hawthorn Bancshares

$23.65

(0.00%)

15:36
10/18/18
10/18
15:36
10/18/18
15:36
Hot Stocks
Hawthorn Bancshares to sell Branson, MO branch »

Hawthorn Bank, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDSO

Medidata

$70.82

1.45 (2.09%)

15:36
10/18/18
10/18
15:36
10/18/18
15:36
Recommendations
Medidata analyst commentary  »

Medidata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ISRG

Intuitive Surgical

$523.21

-19.64 (-3.62%)

15:34
10/18/18
10/18
15:34
10/18/18
15:34
Options
Intuitive Surgical options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

CMCSA

Comcast

$36.11

-0.28 (-0.77%)

15:32
10/18/18
10/18
15:32
10/18/18
15:32
Hot Stocks
Comcast says it is now the largest provider of Gigabit Internet »

Comcast announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PTLA

Portola Pharmaceuticals

$22.02

-1.65 (-6.97%)

15:21
10/18/18
10/18
15:21
10/18/18
15:21
Hot Stocks
Breaking Hot Stocks news story on Portola Pharmaceuticals »

James E. Flynn reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Dec

ETFC

E-Trade

$48.86

-1.71 (-3.38%)

15:19
10/18/18
10/18
15:19
10/18/18
15:19
Options
E Trade options imply 7.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/18/18
10/18
15:17
10/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/18/18
10/18
15:16
10/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTZ

Hertz

$15.11

-1.35 (-8.20%)

15:15
10/18/18
10/18
15:15
10/18/18
15:15
Options
Hertz put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

15:10
10/18/18
10/18
15:10
10/18/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

AXP

American Express

$102.92

-1.47 (-1.41%)

15:04
10/18/18
10/18
15:04
10/18/18
15:04
Options
American Express options imply 4.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 05

    Nov

TEVA

Teva

$21.27

0.08 (0.38%)

15:03
10/18/18
10/18
15:03
10/18/18
15:03
Hot Stocks
FDA reports tentative approval for Actavis' ANDA for Pimecrolimus »

Actavis is a unit of Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ACHC

Acadia

$38.63

2.86 (8.00%)

15:03
10/18/18
10/18
15:03
10/18/18
15:03
Recommendations
Acadia analyst commentary  »

Acadia could be worth $43…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISRG

Intuitive Surgical

$525.36

-17.49 (-3.22%)

14:59
10/18/18
10/18
14:59
10/18/18
14:59
Earnings
Fly Intel: What to watch in Intuitive Surgical earnings report »

Intuitive Surgical (ISRG)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

NTAP

NetApp

$78.07

-0.99 (-1.25%)

14:55
10/18/18
10/18
14:55
10/18/18
14:55
Options
NetApp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

14:50
10/18/18
10/18
14:50
10/18/18
14:50
General news
Canada retail sales preview »

Canada retail sales…

14:50
10/18/18
10/18
14:50
10/18/18
14:50
General news
Canada CPI preview »

Canada CPI preview:…

BKD

Brookdale Senior Living

$8.68

-0.07 (-0.80%)

14:49
10/18/18
10/18
14:49
10/18/18
14:49
Hot Stocks
Brookdale Senior Living moves off lows, said to cancel out of conference »

An afternoon move off the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 11

    Dec

PYPL

PayPal

$77.79

-2.32 (-2.90%)

14:49
10/18/18
10/18
14:49
10/18/18
14:49
Options
PayPal options imply 9.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

GOOG

Alphabet

$1,087.23

-28.76 (-2.58%)

, GOOGL

Alphabet Class A

$1,096.20

-30.47 (-2.70%)

14:47
10/18/18
10/18
14:47
10/18/18
14:47
Hot Stocks
Google opens Hardware Stores in NYC and Chicago »

Google opens pop-up…

GOOG

Alphabet

$1,087.23

-28.76 (-2.58%)

GOOGL

Alphabet Class A

$1,096.20

-30.47 (-2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.